Robotic surgery for young heart patients shortens hospital stay and speeds recovery, study indicates

January 28, 2004

SAN ANTONIO, Texas -- In the first-ever direct comparison of robot-assisted and traditional surgery for children's heart defects, University of Michigan surgeons report that the robot's help reduces patients' recuperation time and surgery-related trauma and scarring, while extending the length of the operation by just over half an hour.

Their finding suggests that the minimally invasive surgical techniques made possible by the surgeon-controlled, camera-guided robot system can give the same surgical result as open-chest techniques, with less impact on the young patient's body.

And although the study group was small, the finding demonstrates that robot-assisted surgery may be a good option for certain defects.

U-M Congenital Heart Center pediatric heart surgeons will present their results here on Jan. 28 at the annual meeting of the Society of Thoracic Surgeons, as part of a workshop for other surgeons on robot-assisted options for young heart patients.

Says surgeon Richard Ohye, M.D., "Robot-assisted surgery has already shown quite a bit of promise in the adult population, including adults who have congenital heart anomalies. But we feel from our experience that it can be used on many pediatric patients weighing more than 10 kilograms, and can reduce hospital stays, operative trauma, cosmetic impact and overall recovery time. And we found it does so with an acceptable impact on a patient's time in the OR."

Despite the added expense of operating room time and the robot itself, Ohye feels that the machine will more than offset its costs over time by reducing the time a child spends in the hospital after surgery, the complications he or she will face during recovery, and his or her parents' time away from work.

Ohye and U-M pediatric cardiac surgery colleagues Edward Bove, M.D. and Eric Devaney, M.D. performed the robot-assisted and open surgeries compared in the report. Ohye and Devaney began using the robot at the U-M's C.S. Mott Children's Hospital in November 2002, one year after the U-M Health System acquired the $1 million da Vinci robot system.

The surgeons use the robot for a small minority of the more than 900 surgical procedures they perform each year on U-M Congenital Heart Center patients, but they expect the number will grow in the future.

The system has two main components: a seven-foot-high robot with three cable-driven that hold tiny instruments and a small camera while they are inserted into the patient's chest through small incisions, and a visualization and guidance station where the surgeon can manipulate the robot arms using three-dimensional images from the camera inside the patient.

The Congenital Heart Center surgeons share the robot with numerous other adult and pediatric surgeons at UMHS, from urologists who use it to remove prostate glands without damaging nearby nerves, to gynecologists who extract fibroids while sparing a woman's uterus.

At the STS meeting, Ohye will show video footage of operations to divide a vascular ring -- a rare birth defect in which blood vessels surround the esophagus and trachea, reducing a child's ability to breathe.

He will also present data on five vascular ring division patients who had a robot-assisted minimally invasive operation, and ten who had conventional open-chest surgery for the same problem. The data also include two other children who had robot-assisted surgery for other congenital heart defects -- a persistent left superior vena cava, and the placement of electrical leads for an implanted pacemaker to correct a heart rhythm irregularity.

The robot-assisted children ranged in age from 1 to 10 years, and the smallest weighed 10 kilograms, since the camera is too large to fit between the ribs of a smaller child.

The seven robot-assisted children had a median hospital stay of two days, compared with four days for children who had open-chest surgery. One patient in each group experienced a complication called a chylothorax, in which a lymphatic duct was punctured and leaked fluid into the chest cavity.

The children who had robot-assisted surgery were in the operating room for a median of 116 minutes, compared with a median of 83 minutes for the open-chest procedures. This difference was statistically significant. But Ohye feels it is not unreasonable, especially given the other positive effects of using the robot.

The U-M team is now offering robot-assisted surgery as an option to the parents of patients with vascular rings and certain other conditions, even as they plan to expand the range of procedures they perform with it.

Someday, they hope that real-time, three-dimensional images of the inside of the heart made by sound wave echos or electromagnetic devices rather than cameras will allow them to perform minimally invasive versions of procedures that involve entering the heart itself. Right now, the imaging techniques are used to aid open-chest procedures.

"In five or so years, perhaps we'll perform most of the basic procedures with the robot's help," Ohye predicts. "But for now, we're starting with building the case for its safety and its cost-effectiveness, in certain types of cases. And we're finding that parents of our patients are embracing it, and in some cases even asking for it."
-end-
The Michigan Congenital Heart Center is one of the world's top centers for the diagnosis and treatment of heart and vascular disorders that arise during fetal development or childhood. Patients are often followed from before birth through adulthood. The MCHC takes a multidisciplinary team approach to patient care, and offers support services to help families cope. More than 900 surgical procedures, 600 heart catheterizations, and thousands of clinic visits take place at the MCHC each year. About half of the MCHC's patients are from within Michigan, but families travel to Ann Arbor from around the country and throughout the world for treatment and surgery.

University of Michigan Health System

Related Congenital Heart Defects Articles from Brightsurf:

Cutting-edge, whole-heart imaging provides new details on heart defects
A cutting-edge technique that allows scientists to zoom into tiny details in a 3D image of a whole animal heart may lead to new insights on congenital heart disease.

Congenital heart defects may not increase the risk of severe COVID-19 symptoms
People with congenital heart disease had a lower-than-expected risk for severe symptoms from COVID-19, a new study has found.

Rare congenital heart defect rescued by protease inhibition
A research team at the Greenwood Genetic Center (GGC) has successfully used small molecules to restore normal heart and valve development in an animal model for Mucolipidosis II (ML II), a rare genetic disorder.

Gout treatment may aid patients with congenital heart disease
A drug used to treat gout, probenecid, may improve heart function in individuals with a particular heart defect, according to results from a small pilot study run by a University of Cincinnati researcher.

Congenital heart disease more deadly in low-income countries
Even though mortality from congenital heart disease (CHD) has declined over the last three decades as diagnosis and treatments have advanced, a new study shows that the chances for a child to survive a CHD diagnosis significantly differs based on the country where he or she is born.

Genomics experts dispute nine genes linked to congenital heart condition
The Clinical Genome Resource's (ClinGen) expert panel has critically reevaluated the scientific evidence for all 17 reported genes linked to long QT syndrome, disputing nine of the genes and revealing only three of the genes to be definitively associated with the most common form of the disease.

Physicians should consider HCQ to reduce the risk of recurrent congenital heart block
New research findings presented at the 2019 ACR/ARP Annual Meeting discovered that hydroxychloroquine (HCQ) significantly reduces the recurrence rate of congenital heart block in subsequent pregnancies of women with anti-SSA/ Ro antibodies, regardless of their health status.

Faulty signalling pathway linked to congenital heart condition
Faulty signalling pathway causes the heart to develop unnaturally while in the embryo stage, according to Duke-NUS Medical School researchers.

A new framework to study congenital heart defects
In a new study published in the scientific journal Nature, a team of researchers at the Gladstone Institutes, in collaboration with the University of Luxembourg, reveal for the first time the full spectrum of cells that come together to make a heart at the earliest stages of embryo formation.

Greater prevalence of congenital heart defects in high intensity oil and gas areas
Mothers living near more intense oil and gas development activity have a 40-70% higher chance of having children with congenital heart defects (CHDs) compared to those living in areas of less intense activity, according to a new study from researchers at the Colorado School of Public Health.

Read More: Congenital Heart Defects News and Congenital Heart Defects Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.